C M Schmidt
Overview
Explore the profile of C M Schmidt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
81
Citations
765
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McGuire S, Anderson M, Maatman T, Roch A, Butler J, Ceppa E, et al.
Am J Surg
. 2023 Feb;
225(5):927-930.
PMID: 36792453
Background: Rates of opioid usage during necrotizing pancreatitis (NP) disease course are unknown. We hypothesized that a significant number of NP patients were prescribed opioid analgesics chronically. Methods: Single institution...
2.
Flick K, Soufi M, Yip-Schneider M, Simpson R, Colgate C, Nguyen T, et al.
J Gastrointest Surg
. 2021 Mar;
25(11):2902-2907.
PMID: 33772404
Background: The decision to routinely leave a nasogastric tube after pancreatoduodenectomy remains controversial. We sought to determine the impact of immediate nasogastric tube removal versus early nasogastric tube removal (<24...
3.
Maatman T, Westfall-Snyder J, Ceppa E, House M, Nakeeb A, Nguyen T, et al.
Dig Dis Sci
. 2021 Jan;
66(12):4485-4491.
PMID: 33464454
Background: Necrotizing pancreatitis (NP) is caused by hypertriglyceridemia (HTG) in up to 10% of patients. Clinical experience suggests that HTG-NP is associated with increased clinical severity; objective evidence is limited...
4.
Flick K, Al-Temimi M, Maatman T, Sublette C, Swensson J, Nakeeb A, et al.
J Gastrointest Surg
. 2020 Jul;
24(9):2008-2014.
PMID: 32671796
Background: This study aimed to determine the incidence of new onset hepatic steatosis after neoadjuvant chemotherapy for pancreatic cancer and its impact on outcomes after pancreatoduodenectomy. Methods: Retrospective review identified...
5.
Maatman T, Nicolas M, Westfall-Snyder J, Ceppa E, House M, Nakeeb A, et al.
Am J Surg
. 2020 Mar;
219(3):513-514.
PMID: 32199538
No abstract available.
6.
Yip-Schneider M, Soufi M, Carr R, Flick K, Wu H, Schmidt C
Am J Surg
. 2020 Mar;
219(3):496.
PMID: 32199536
No abstract available.
7.
Simpson R, Fennerty M, Flick K, Colgate C, Ceppa E, House M, et al.
Am J Surg
. 2020 Mar;
219(3):394-395.
PMID: 32199527
No abstract available.
8.
Flick K, Simpson R, Soufi M, Fennerty M, Yip-Schneider M, Colgate C, et al.
Am J Surg
. 2020 Feb;
220(4):972-975.
PMID: 32087986
Background: This study evaluated closure techniques and incisional surgical site complications (SSCs) and incisional surgical site infections (SSIs) after pancreaticoduodenectomy (PD). Methods: Retrospective review of open PDs from 2015 to...
9.
Simpson R, Cockerill N, Yip-Schneider M, Ceppa E, House M, Zyromski N, et al.
HPB (Oxford)
. 2018 Oct;
21(5):574-581.
PMID: 30293868
Background: For pancreatic cysts with negative cytology, Integrated Molecular Pathology (IMP) is a malignancy risk score integrating clinical criteria with pancreatic cyst fluid DNA profiling. Aside from main pancreatic duct...
10.
Carr R, Roch A, Shaffer K, Aboudi S, Schmidt 2nd C, DeWitt J, et al.
Am J Surg
. 2017 Jan;
213(3):494-497.
PMID: 28129918
Background: Patients with intraductal papillary mucinous neoplasm (IPMN) are at risk for invasive pancreatic cancer. We aim to characterize the impact of smoking on IPMN malignant progression. Methods: Patients undergoing...